Clinuvel Pharmaceuticals Ltd (OTC Pink - Current Information:CLVLY)

2.15
Delayed Data
As of 12:51pm ET
 -0.06 / -2.71%
Today’s Change
1.38
Today|||52-Week Range
5.00
-37.10%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$94.0M

Company Description

Clinuvel Pharmaceuticals Ltd. operates as a global biopharmaceutical company. It is focused on the development of SCENESSE, its proprietary photoprotective drug. The company also focuses on developing drugs for the treatment of severe skin disorders. Clinuvel Pharmaceuticals was founded on December 14, 1999 and is headquartered in Melbourne, Australia.

Contact Information

Clinuvel Pharmaceuticals Ltd.
190 Queen Street
Melbourne Victoria (vic) 3000
P:(139) 660-4900
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Philippe J. WolgenChief Executive Officer, Director & MD
Darren M. KeamyChief Financial Officer & Secretary
Dennis J. WrightChief Scientific Officer
Lachlan HayMedia Relations

To view my watchlist

Not a member yet?

Sign up now for a free account